366 related articles for article (PubMed ID: 20020776)
1. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors.
Hao J; Ho JN; Lewis JA; Karim KA; Daniels RN; Gentry PR; Hopkins CR; Lindsley CW; Hong CC
ACS Chem Biol; 2010 Feb; 5(2):245-53. PubMed ID: 20020776
[TBL] [Abstract][Full Text] [Related]
2. Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists.
Cannon JE; Upton PD; Smith JC; Morrell NW
Br J Pharmacol; 2010 Sep; 161(1):140-9. PubMed ID: 20718746
[TBL] [Abstract][Full Text] [Related]
3. Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity.
Alsamarah A; LaCuran AE; Oelschlaeger P; Hao J; Luo Y
PLoS One; 2015; 10(7):e0132221. PubMed ID: 26133550
[TBL] [Abstract][Full Text] [Related]
4. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism.
Yu PB; Hong CC; Sachidanandan C; Babitt JL; Deng DY; Hoyng SA; Lin HY; Bloch KD; Peterson RT
Nat Chem Biol; 2008 Jan; 4(1):33-41. PubMed ID: 18026094
[TBL] [Abstract][Full Text] [Related]
5. A phenotypic screen in zebrafish identifies a novel small-molecule inducer of ectopic tail formation suggestive of alterations in non-canonical Wnt/PCP signaling.
Gebruers E; Cordero-Maldonado ML; Gray AI; Clements C; Harvey AL; Edrada-Ebel R; de Witte PA; Crawford AD; Esguerra CV
PLoS One; 2013; 8(12):e83293. PubMed ID: 24349481
[TBL] [Abstract][Full Text] [Related]
6. Development of an ALK2-biased BMP type I receptor kinase inhibitor.
Mohedas AH; Xing X; Armstrong KA; Bullock AN; Cuny GD; Yu PB
ACS Chem Biol; 2013; 8(6):1291-302. PubMed ID: 23547776
[TBL] [Abstract][Full Text] [Related]
7. Applications of small molecule BMP inhibitors in physiology and disease.
Hong CC; Yu PB
Cytokine Growth Factor Rev; 2009; 20(5-6):409-18. PubMed ID: 19914855
[TBL] [Abstract][Full Text] [Related]
8. Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification.
Lin T; Wang XL; Zettervall SL; Cai Y; Guzman RJ
J Vasc Surg; 2017 Aug; 66(2):586-593. PubMed ID: 27374065
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.
Engers DW; Frist AY; Lindsley CW; Hong CC; Hopkins CR
Bioorg Med Chem Lett; 2013 Jun; 23(11):3248-52. PubMed ID: 23639540
[TBL] [Abstract][Full Text] [Related]
10. A new class of small molecule inhibitor of BMP signaling.
Sanvitale CE; Kerr G; Chaikuad A; Ramel MC; Mohedas AH; Reichert S; Wang Y; Triffitt JT; Cuny GD; Yu PB; Hill CS; Bullock AN
PLoS One; 2013; 8(4):e62721. PubMed ID: 23646137
[TBL] [Abstract][Full Text] [Related]
11. Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells.
Hao J; Daleo MA; Murphy CK; Yu PB; Ho JN; Hu J; Peterson RT; Hatzopoulos AK; Hong CC
PLoS One; 2008 Aug; 3(8):e2904. PubMed ID: 18682835
[TBL] [Abstract][Full Text] [Related]
12. The specificities of small molecule inhibitors of the TGFß and BMP pathways.
Vogt J; Traynor R; Sapkota GP
Cell Signal; 2011 Nov; 23(11):1831-42. PubMed ID: 21740966
[TBL] [Abstract][Full Text] [Related]
13. DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells.
Ao A; Hao J; Hopkins CR; Hong CC
PLoS One; 2012; 7(7):e41627. PubMed ID: 22848549
[TBL] [Abstract][Full Text] [Related]
14. Application of small organic molecules reveals cooperative TGFβ and BMP regulation of mesothelial cell behaviors.
Cross EE; Thomason RT; Martinez M; Hopkins CR; Hong CC; Bader DM
ACS Chem Biol; 2011 Sep; 6(9):952-61. PubMed ID: 21740033
[TBL] [Abstract][Full Text] [Related]
15. DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer.
Hao J; Lee R; Chang A; Fan J; Labib C; Parsa C; Orlando R; Andresen B; Huang Y
PLoS One; 2014; 9(6):e90748. PubMed ID: 24603907
[TBL] [Abstract][Full Text] [Related]
16. Dorsomorphin stimulates neurite outgrowth in PC12 cells via activation of a protein kinase A-dependent MEK-ERK1/2 signaling pathway.
Kudo TA; Kanetaka H; Mizuno K; Ryu Y; Miyamoto Y; Nunome S; Zhang Y; Kano M; Shimizu Y; Hayashi H
Genes Cells; 2011 Nov; 16(11):1121-32. PubMed ID: 21988724
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
[TBL] [Abstract][Full Text] [Related]
18. Directed cardiomyogenesis of human pluripotent stem cells by modulating Wnt/β-catenin and BMP signalling with small molecules.
Aguilar JS; Begum AN; Alvarez J; Zhang XB; Hong Y; Hao J
Biochem J; 2015 Jul; 469(2):235-41. PubMed ID: 26171831
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein signaling promotes morphogenesis of blood vessels, wound epidermis, and actinotrichia during fin regeneration in zebrafish.
Thorimbert V; König D; Marro J; Ruggiero F; Jaźwińska A
FASEB J; 2015 Oct; 29(10):4299-312. PubMed ID: 26148971
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation.
Yoshioka Y; Ono M; Osaki M; Konishi I; Sakaguchi S
Eur J Immunol; 2012 Mar; 42(3):749-59. PubMed ID: 22144105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
